Dynavax Clears Heplisav-B Hurdle With CDC Recommendation By: Benzinga via Benzinga February 21, 2018 at 10:32 AM EST What Happened Dynavax Technologies Corporation (NASDAQ: DVAX) traded up 3.7 percent Wednesday after management announced the Centers ... Read More >> Related Stocks: Dynavax Technologies Victory US Eqty Income Ehnd Vol Wtd ETF